Kobayashi Pharmaceutical Co's total assets for Q2 2024 were ¥262.25B, an increase of 0.38% from the previous quarter. KBYPF total liabilities were ¥52.52B for the fiscal quarter, a -6.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.